Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 167 is a processed pseudogene—an inactive, non-coding genomic sequence derived from the ancestral 5S ribosomal RNA gene[1][2][6]. 5S rRNA is a structural RNA playing a key role in ribosome assembly and function in eukaryotes[3][5], but pseudogenes like RNA5SP167 do not encode functional RNA and are typically considered genomic relics. Pseudogenes are increasingly studied for their potential roles as regulatory non-coding RNAs or disease biomarkers, yet there is no evidence that RNA5SP167 has such functional impact[1][4][6]. Thus, it is not considered a molecular target, and its listing as a “receptor” or target would be incorrect.
None reported for drugs targeting this molecule
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 167 (RNA5SP167).